Moreover, TRIM44-mediated SQSTM1 oligomerization through phosphorylation at S349 boosts KEAP1 sequestration and NRF2 signaling, supporting PI-resistant MM cell survival. The gene discussed is KEAP1; the disease is Miyoshi myopathy.